Teva Pharmaceutical Industries (TEV) News Today → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free TEV Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSupreme Court Denies Vanda Pharma' Petition In HETLIOZ Litigation Against Teva, Apotexmarkets.businessinsider.com - April 22 at 10:33 PMUPDATE 1-U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patentsfinance.yahoo.com - April 22 at 12:32 PMTeva Confirms Austedo's Effectiveness For HD Chorea With The 4-week Titration Kitmarkets.businessinsider.com - April 16 at 12:32 PMTeva joins world’s top 20 pharmaceutical companiesmsn.com - April 16 at 12:32 PMTEVA May 2024 10.000 putfinance.yahoo.com - April 14 at 1:35 AMAldi Just Dropped $10 Teva Sandal Dupes & They’re Nearly Identical to the Originalsmsn.com - April 4 at 4:03 PMTeva Announces Strategic Alliance With MAbxience For Oncology Biosimilar Candidatemarkets.businessinsider.com - April 4 at 11:03 AMTeva sandals are nearly 50% off right now at Nordstrom Rackmsn.com - April 3 at 7:11 PMUroGen Pharma Files Patent Infringement Action Against Teva Pharmaceuticalsfinance.yahoo.com - April 3 at 9:11 AMUroGen Pharma Files Patent Infringement Lawsuit Against Teva Pharmamarkets.businessinsider.com - April 3 at 9:11 AMTeva, Viatris win new chance to challenge J&J schizophrenia drug patentfinance.yahoo.com - April 1 at 12:00 PMTeva on track for seventh straight day of gainsmsn.com - March 27 at 3:23 PMTeva UK and Closed Loop Medicine announce strategic partnership to advance development of personalised medicinesmsn.com - March 26 at 10:56 AMTeva Collaborations Through the Years: Ugg, Anna Sui and Moreyahoo.com - March 19 at 5:17 PMNow That Two Inhaler Makers Are Capping Patient Costs, Will More Follow?finance.yahoo.com - March 18 at 6:40 PMIsrael stocks higher at close of trade; TA 35 up 1.14%msn.com - March 18 at 1:40 PMGlobal Fibrate Drugs Market 10 Year Forecast Report 2024-2034, by Drug Type, by Product Type, by Distribution Channel and By Regionfinance.yahoo.com - March 18 at 8:40 AMTEVA Mar 2024 11.500 calluk.finance.yahoo.com - March 17 at 7:45 PMTEVA Apr 2024 7.000 callfinance.yahoo.com - March 17 at 9:42 AMTEVA Mar 2024 8.000 callca.finance.yahoo.com - March 16 at 8:01 AMTEVA Mar 2024 11.000 putfinance.yahoo.com - March 15 at 11:17 PMTEVA Mar 2024 14.000 callfinance.yahoo.com - March 15 at 11:17 PMTEVA May 2024 13.000 putfinance.yahoo.com - March 15 at 8:15 AMTeva Pharmaceutical Industries Ltd. ADRbarrons.com - March 12 at 7:37 AMTEVA Apr 2024 13.000 callfinance.yahoo.com - March 10 at 9:29 PMTEVA Mar 2024 9.500 putfinance.yahoo.com - March 8 at 10:40 PMTeva upgraded at J.P. Morgan on upcoming catalystsmsn.com - March 8 at 12:40 PM8 Analysts Assess Teva Pharmaceutical Indus: What You Need To Knowmarkets.businessinsider.com - March 8 at 12:40 PMEVP, CFO Eliyahu Kalif Sells 77,550 Shares of Teva Pharmaceutical Industries Ltd (TEVA)finance.yahoo.com - March 8 at 7:40 AMTEVA Apr 2024 9.000 callfinance.yahoo.com - March 7 at 9:24 AMTEVA Mar 2024 15.500 callfinance.yahoo.com - March 7 at 12:31 AMTEVA Sep 2024 15.000 callfinance.yahoo.com - March 6 at 7:31 PMTEVA Apr 2024 13.500 putfinance.yahoo.com - March 4 at 7:03 PMTEVA Mar 2024 13.500 putuk.finance.yahoo.com - March 3 at 8:46 PMTEVA Mar 2024 11.000 callca.finance.yahoo.com - February 29 at 8:39 AMTEVA Jun 2024 20.000 callfinance.yahoo.com - February 27 at 3:45 PMAlvotech/Teva win FDA approval for Humira biosimilarmsn.com - February 26 at 8:35 AMTeva and Jiangsu Nhwa Forge Strategic Partnership to Promote Patient Access to AUSTEDO® in Chinafinance.yahoo.com - February 26 at 8:35 AMTEVA Apr 2024 13.500 callfinance.yahoo.com - February 25 at 5:06 PMTEVA Mar 2024 21.000 callfinance.yahoo.com - February 23 at 11:43 PMTeva Pharmaceuticals Announces Positive Data For Anti-TL1A Assetmarkets.businessinsider.com - February 20 at 2:51 PMTeva Pharma CEO Dismisses Split Speculations Expects Significant Interest For Its API Business Divestiture: Reportmsn.com - February 20 at 2:51 PMTeva Pharm to stay as unified drugmaker, sees big interest in API business, says CEOyahoo.com - February 20 at 9:50 AMTeva Presents New Data Supporting Safety, Tolerability and Target Engagement of Anti-TL1A (TEV-‘574) Antibody at the 2024 ECCO Annual Meetingfinance.yahoo.com - February 20 at 9:50 AMTeva Pharm to stay as unified generics, branded drugmaker -CEO saysfinance.yahoo.com - February 20 at 4:50 AMUPDATE 1-Teva Pharm to stay as unified generics, branded drugmaker, CEO saysfinance.yahoo.com - February 20 at 4:50 AMA Review Of Teva's Prospectsseekingalpha.com - February 15 at 7:45 AMTeva Pharmaceutical Industries Limited (NYSE:TEVA) Just Reported And Analysts Have Been Lifting Their Price Targetsfinance.yahoo.com - February 2 at 8:05 AMTeva Pharma sees lower 2024 profit but higher sales after large Q4 beatmsn.com - February 2 at 1:52 AMTeva Pharmaceutical Shares Hit 52-Week High After 4Q Earnings Beats Estimatesmarketwatch.com - January 31 at 1:16 PM Get Teva Pharmaceutical Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for TEV and its competitors with MarketBeat's FREE daily newsletter. Email Address “Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers. Find out why right here (and see what you can do to get in too with just a few dollars). TEV Media Mentions By Week TEV Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TEV News Sentiment▼0.370.39▲Average Medical News Sentiment TEV News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TEV Articles This Week▼23▲TEV Articles Average Week Get Teva Pharmaceutical Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for TEV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Fielmann Group News Fresenius SE & Co. KGaA News Genfit News Sanofi News Sartorius Aktiengesellschaft News Sartorius Stedim Biotech News Evotec News Merck KGaA News Medigene News Drägerwerk AG & Co. KGaA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (FRA:TEV) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe World's First "$20 Trillion Drug?"Behind the MarketsI’m afraid WWIII is a very real possibility Porter & CompanyThe Next Nvidia?InvestorPlaceExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teva Pharmaceutical Industries Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
